Insider · CIK 0001921560
Brent Lalomia
Files at CNMD (CONMED Corp). First filing -, latest -.
In brief
Brent Lalomia files SEC Form 4 as officer at CNMD (CONMED Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Brent Lalomia has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | CNMD CONMED Corp | AGrant or award RSUs (Restricted Stock Units)derivative | +17,198 | $0.00 | $0 | 17,198 | Mar 18, 2026 |
| Mar 6, 2026 | CNMD CONMED Corp | MOption exercise Common Stock | +75 | $0.00 | $0 | 941 | Mar 10, 2026 |
| Mar 6, 2026 | CNMD CONMED Corp | FTax withholding Common Stock | -26 | $39.90 | $1,037 | 915 | Mar 10, 2026 |
| Mar 6, 2026 | CNMD CONMED Corp | MOption exercise RSUs (Restricted Stock Units)derivative | -75 | $0.00 | $0 | 0 | Mar 10, 2026 |
| Mar 2, 2026 | CNMD CONMED Corp | AGrant or award RSUs (Restricted Stock Units)derivative | +9,554 | $0.00 | $0 | 9,554 | Mar 4, 2026 |
| Mar 2, 2026 | CNMD CONMED Corp | AGrant or award Options To Purchase Common Stockderivative | +11,322 | $0.00 | $0 | 11,322 | Mar 4, 2026 |
| Mar 7, 2025 | CNMD CONMED Corp | MOption exercise Common Stock | +75 | $0.00 | $0 | 1,032 | Mar 11, 2025 |
| Mar 7, 2025 | CNMD CONMED Corp | FTax withholding Common Stock | -26 | $62.74 | $1,631 | 1,006 | Mar 11, 2025 |
| Mar 7, 2025 | CNMD CONMED Corp | MOption exercise RSUs (Restricted Stock Units)derivative | -75 | $0.00 | $0 | 75 | Mar 11, 2025 |
| Mar 3, 2025 | CNMD CONMED Corp | AGrant or award Options To Purchase Common Stockderivative | +26,895 | $0.00 | $0 | 26,895 | Mar 5, 2025 |
| Mar 7, 2024 | CNMD CONMED Corp | MOption exercise Common Stock | +75 | $0.00 | $0 | 983 | Mar 11, 2024 |
| Mar 7, 2024 | CNMD CONMED Corp | FTax withholding Common Stock | -26 | $85.00 | $2,210 | 957 | Mar 11, 2024 |
| Mar 7, 2024 | CNMD CONMED Corp | MOption exercise Rsus (restricted Stock Units)derivative | -75 | $0.00 | $0 | 150 | Mar 11, 2024 |
| Mar 1, 2024 | CNMD CONMED Corp | AGrant or award Options To Purchase Common Stockderivative | +18,988 | $0.00 | $0 | 18,988 | Mar 5, 2024 |
Questions about Brent Lalomia
Answered from the filings on this page, as of the latest one.
Is Brent Lalomia buying or selling?
Brent Lalomia has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Brent Lalomia's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Brent Lalomia has 0.
Where does Brent Lalomia file Form 4?
Brent Lalomia has filed Form 4 at CNMD (CONMED Corp) as Vice President QA and RA. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.